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Rationale: Asthma is a chronic inflammatory disease of the airways that is very common (7.9% of 
Canadians over the age of 12). Despite numerous clinical guidelines, education events and administrative 
data reviews, there has been little change to the way asthma is managed in the Canadian health care 
system for nearly 30 years. We evaluated, through the Physician Learning Program (PLP) in Alberta, 
possible reasons why administrative datasets have not been able to provide meaningful information to 
adjust health policy.
Methods: Provincial data was attained through Alberta Health Service and Alberta Health on pulmonary 
function testing from 2005-2011 (through the PLP). The number of asthma diagnosis made during the same 
time frame were then compared.
Results: The preliminary results of the PLP found that spirometry was billed for roughly half as often as 
the asthma diagnostic codes were utilized during the same time frame. However, the review also revealed 
inconsistencies in how administrative data are captured, making it difficult to determine whether 
spirometry is being underutilized by physicians in making asthma diagnoses. 
Conclusions: Inconsistencies in how administrative data are captured in Alberta may be contributing 
to an incomplete picture of the rates of asthma diagnosis and physiological testing, and may explain, in 
part, the limited influence of administrative datasets on guiding meaningful change within the healthcare 
system.  
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Asthma is a prevalent disease for which 
numerous clinical guidelines, educational events 
and administrative data reviews have been 
implemented to guide asthma care. However, 
despite these resources being readily available to 
health care workers (HCWs) and administrators, 
it has not significantly changed the way in 
which asthma is managed in the Canadian 
health care system since the first Canadian 
guidelines were introduced in 1989. Numerous 
clinical guidelines and educational events have 
been implemented over this period; however, 
regional, provincial and national administrative 
datasets have been unable to assist health 
care providers [1,2,3]. Consequently, significant 
morbidity and mortality rates of asthma patients 
continue to cost the health care system. 
 
The cost of respiratory diseases, excluding lung 
cancer, account for the fourth largest health care 
cost in Canada [4]. The direct costs of asthma 
are estimated at $600 million per year. Asthma 
leads  not only to direct costs from services such 
as physician visits, emergency visits, diagnostic 
tests and drug costs, but also to indirect costs 
from sources such as lost time from work [5]. 
According to Statistics Canada, in 2014, 8.1% of 
Canadians (2.9 million) 12 years of age and older 
reported having had a diagnosis of asthma from 
a health professional [6]. This disease accrues a 
mortality of 500 adults each year and is responsible 
for 20% of school absences in Canada [7].
 
Multiple publications over the past 15 years have 
indicated that 1 in 3 physician-diagnosed asthma 
cases are not in fact, asthma [10,11]. This includes 
over 700,000 Canadians who may be misdiagnosed 
with asthma. The diagnosis of asthma, which may 
become a lifelong label, should not be made in the 
absence of timely pulmonary physiologic testing 
(i.e. spirometry, pulmonary function tests [PFTs]) 
and airway challenge tests in conjunction with 
appropriate respiratory symptoms [8, 9]. However, 
although the Canadian Respiratory Guidelines have 
outlined best practices for treatment of asthma, a 
Canadian study found that only 39% of physicians 
surveyed made treatment recommendations based 
on the Canadian Respiratory Guidelines [10]. A Nova 
Scotia study found that only 52.2% of their 90 self-
referred participants who had a diagnosis of asthma 
reported having received pulmonary function 
testing, and 62% of the participants were being 
treated with long-term asthma medications despite 
not meeting the combined clinical and physiological 
test criteria for a diagnosis of asthma [11]. 
Spirometry is a simple, cost effective test used 
in the diagnosis of respiratory diseases. This 
physiologic testing is essential in asthma diagnosis; 
however, it should never be used as a stand-alone 
diagnostic test. It must be taken into consideration 
after a thorough clinical pre-test likelihood is 
evaluated [21]. If diagnosis is made without 
spirometry testing, contradictory to the Canadian 
Respiratory Guidelines, asthma misdiagnosis may 
occur. Diagnosis of asthma may result in patients 
being prescribed medications, and if based on 
an incorrect diagnosis, this could be dangerous, 
unnecessary and costly to both the patient and 
the health care system. There are also side 
effects associated with some of the prescription 
medications used for asthma; for example, β2-
agonists have been found to increase cardiovascular 
death, and therefore pose a risk for individuals with 
cardiovascular disease [17]. Owing to the potential 
for unnecessary financial burden and health risks, 
it is important to ensure that an accurate diagnosis 
of asthma is made and managed correctly.
This study aims to evaluate possible reasons 
why provincial, national and territorial 
administrative datasets, to date, have not 
been able to provide meaningful solutions 
for this critical health care problem.
Introduction
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The Physician Learning Program (PLP), an Alberta 
Medical Association benefit stream program, 
is a collaboration between the University of 
Alberta and University of Calgary. This program 
provides physicians with personal data in a 
manner to inform practice and modify behavior 
within their practice setting, an example of best 
practice through knowledge translation [12].
 
A panel of asthma experts had a project approved 
by the PLP steering committee (College of 
Physicians and Surgeons of Alberta (CPSA), 
Alberta Health Services (AHS) and Alberta 
Health (AH)). The project aim was to examine 
the question of asthma over-diagnosis and 
relevant data. Ethics approval was sought and 
obtained through the University of Alberta 
research ethics board. Access to administrative 
datasets held by AHS and AH were made available 
to the panel. The process carried out by the 
Edmonton PLP for its projects is shown in Figure 1.
Provincial asthma data on pulmonary function 
testing were collected from 2005-2011 to 
compare with the number of asthma diagnosis 
made during the same time frame. The project 
did not proceed beyond the expert panel 
review due to problems encountered with data. 
Results
Data inconsistencies became apparent through 
the extraction process in terms of: (i) Physician 
and Pulmonary function test (PFT) lab billing; and, 
(ii) Data capture from public versus private PFT 
labs. Variance in primary care physician billings 
for spirometry was noted. Figure 2 shows the 
available respiratory testing data in Alberta, using 
the spirometry testing code 03.38C Health Service 
Methods
The PLP Process 
Figure 1: The PLP Edmonton project process 
Image supplied by the PLP. 
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Code and the asthma diagnosis Diagnostic 
Codes 493 (asthma), 493.0 (extrinsic asthma), 
493.1 (intrinsic asthma) and 493.9 (asthma, 
unspecified), that were collected during three 
different time periods between 2005 and 2011. 
The unique asthma diagnostic codes for newly 
diagnosed asthma were employed between 14660 
and 16928 times, yet spirometry was only billed 
for between 6798 and 10323 times or roughly half 
as often as the asthma diagnostic codes.
Discussion
Our study showed that Alberta’s current system to 
capture pulmonary physiology as assessed by the 
PLP is not adequate. We used provincial asthma 
data on pulmonary function testing performed 
between 2005 and 2011, along with data on asthma 
diagnosis made during the same time period. 
Due to problems with data extraction caused by 
inconsistencies in physician and PFT lab billing 
as well as differences in billing between private 
and public labs, the project was never completed. 
Pulmonary physiology, in addition to a detailed 
history, is essential to the diagnosis of asthma. 
Asthma overdiagnosis poses health services 
concerns which can be impacted by pulmonary 
physiology testing, and where testing is done 
[18]. The current process for interpretation of 
pulmonary physiology is coordinated through the 
CPSA and involves four levels. To perform and 
report lung function tests, physicians must obtain 
CPSA approval as at least a level II physician, 
which requires a specialist in respiratory medicine, 
internal medicine, anesthesia or pediatrics 
to receive training for one month in a lab that 
performs 500 level III studies each year, unless it 
is being performed as office spirometry [13,14]. 
Physiology testing may be categorized under 
numerous different billing codes (i.e. vitalometry, 
spirometry, flow volume loops; as set out in 
the April 2015 Schedule of Medical Benefits – 
explanatory codes released by Alberta Health) 
[15]. There are considerable inconsistencies in 
billing codes selected by physicians. Data capture 
using the spirometry billing code may under-
represent the true number of pulmonary function 
Figure 2: The initial results of the PLP respiratory testing project showing spirometry based on the 03.38C Health 
Service Code and asthma diagnosis based on Diagnostic Codes 493 (asthma), 493.0 (extrinsic asthma), 493.1 
(intrinsic asthma) and 493.9 (asthma, unspecified).
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tests being performed. Physicians may also bill 
separately for performing these tests, versus 
interpreting the results. They are also permitted 
to bill separately for each component of a test. 
This could lead data analysts to overestimate 
the number of tests being performed.
The preliminary PLP data we report here 
found that spirometry was billed for roughly 
half as often as the asthma diagnostic codes 
were utilized during the same time frame. The 
discrepancy between asthma diagnosis and use 
of spirometric testing is concerning, especially 
because of the essential nature of spirometry in 
asthma diagnosis. If the method of data capture 
for the PLP project had provided reliable data, 
then it could be concluded that spirometry is not 
consistently utilized by physicians in order to 
diagnose asthma, and as such these individuals 
may have an inaccurate and costly diagnosis. 
To further compound the potential data capture 
errors, Alberta and other provinces have seen a 
profusion of private labs over recent years whose 
regulatory oversight may differ from provincial 
labs. Medical laboratory services are one of 
the most privatized medical services offered 
in Canada, and for-profit laboratories differ in 
several ways from public services. Firstly, for-
profit laboratories tend to have less accountability 
because of their limited transparency, which 
is caused by their ability to limit disclosure of 
business information [16]. Secondly, for-profit 
laboratories pose a challenge to integration of 
health care information since in some provinces 
they fall under separate administrative structure, 
have different payment structure and separate 
data networks [16]. Potential inconsistencies 
in information disclosure in private labs may 
also contribute to knowledge gaps, and further 
affect the way data is managed in Alberta. 
The PLP is not the first to encounter problems 
gathering reliable data from healthcare databases 
and this challenge is not unique to Alberta, or even 
Canada. Silva-Costa and colleagues examined the 
issues associated with a central database in the 
Ministry of Health’s Central Administration for the 
Health System (ACSS), which receives electronic 
hospital records from Portuguese hospitals daily 
[19].  They found major discrepancies between 
the data when obtained directly from the specific 
hospitals as opposed to when obtained from 
the ACSS. This could produce inaccuracies in 
the results of studies performed using the ACSS 
aggregated data [19]. A study by Scarlett et al also 
found inconsistencies in the Kaiser admissions 
database, specifically looking at ethnicity data 
of patients from five Northern California medical 
centers [20]. They compared patient self-
reported ethnicity with what was documented 
in the Kaiser admissions database and found 
discrepancies, especially among individuals of 
Asian, Hispanic and Aboriginal descent. These 
raise concerns at the level of data reporting [20]. 
While health administrative data offer a unique 
source of province-wide data, on a scale 
not obtainable from a chart or clinic review; 
the usefulness of the data is limited by the 
discrepancies in reporting. Administrative data 
should be used not only as a basis for policy 
making, but also as a method to inform individual 
physician’s practice. It is thus important to 
have data that is both accurate and relevant 
to a clinical setting. Through this review it has 
been revealed that how administrative data is 
captured may lead to an incomplete picture and 
that there may be gaps in data capture which may 
deter health professionals from implementing 
changes based on conclusions from such studies. 
We have found that the current administrative 
system is in need of improvement to better 
link private for-profit PFT labs in conjunction 
with private not-for-profit PFT labs (i.e. AHS), 
into a common administrative database such 
that the province of Alberta has more robust 
data gathering capacity for quality assurance 
/quality control reviews related to asthma. 
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